Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Woodrow currently holds 126,750 shares of Paratek Pharmaceuticals, Inc. (PRTK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Woodrow has been a net seller of PRTK stock. They have purchased $0 and sold $1.3M worth of shares.
Adam Woodrow's most recent insider trade was on Sep 21, 2023, when they sold 622,284 shares at $0.00 per share.
Adam Woodrow serves as Executive at Paratek Pharmaceuticals, Inc. (PRTK). They have executed 45 insider transactions totaling $1.3M over their tenure at the company.
Adam Woodrow holds the position of Executive at Paratek Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Adam Woodrow has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Adam Woodrow was on Jun 4, 2021, when they sold $166.7K worth of PRTK shares. This transaction involved 17,182 shares at $9.70 per share.
Adam Woodrow currently owns 126,750 shares of Paratek Pharmaceuticals, Inc. (PRTK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Woodrow's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Woodrow has 45 Form 4 filings on record as an insider at Paratek Pharmaceuticals, Inc..
Set alerts for Adam Woodrow and 40,000+ other insiders.